Walgreens Boots Alliance (NASDAQ:WBA) posted its quarterly earnings results on Thursday. The pharmacy operator reported $1.02 earnings per share for the quarter, beating the consensus estimate of $0.96 by $0.06, MarketWatch Earnings reports. Walgreens Boots Alliance had a net margin of 0.55% and a return on equity of 19.43%. The firm had revenue of $34.75 billion during the quarter, compared to the consensus estimate of $34.36 billion. During the same period in the previous year, the firm posted $1.43 earnings per share. The business’s revenue was up 2.3% compared to the same quarter last year.
Walgreens Boots Alliance stock opened at $37.41 on Friday. Walgreens Boots Alliance has a fifty-two week low of $33.88 and a fifty-two week high of $64.50. The stock has a market cap of $32.42 billion, a PE ratio of 45.62, a price-to-earnings-growth ratio of 1.35 and a beta of 0.43. The firm’s 50-day simple moving average is $36.42 and its 200 day simple moving average is $40.52. The company has a debt-to-equity ratio of 0.57, a quick ratio of 0.33 and a current ratio of 0.69.
Several research firms have weighed in on WBA. SunTrust Banks decreased their price target on shares of Walgreens Boots Alliance from $42.00 to $40.00 and set a “hold” rating for the company in a research note on Friday, July 10th. Raymond James reiterated a “hold” rating on shares of Walgreens Boots Alliance in a report on Monday, September 7th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of Walgreens Boots Alliance from $43.00 to $38.00 and set a “hold” rating for the company in a report on Friday, July 10th. Royal Bank of Canada reduced their price objective on shares of Walgreens Boots Alliance from $45.00 to $38.00 and set a “sector perform” rating for the company in a report on Wednesday, September 2nd. Finally, BidaskClub cut shares of Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Wednesday. Five analysts have rated the stock with a sell rating and fourteen have given a hold rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $43.19.
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.
Recommended Story: What is intrinsic value?
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.